Indian Economic Survey 2025: Call for Systematic Pharma, Healthcare Deregulation, Stronger R&D Focus

Efficiency, Lower Bureaucratic Hurdles Eyed

 
• By Shubham Singh

In addition to deregulation, the Economic Survey 2025 highlights the pressing need for greater innovation and R&D in India’s pharmaceutical industry.

India economy
(Shutterstock)
Shubham Singh

Read more by Shubham Singh

Shubham Singh is a journalist with seven years of experience covering business and consumer technology. As a Reporter for MedTech Insight, he covers policy, regulation, and digital tech. Outside work, Shubham is an avid traveler, foodie, and fitness enthusiast, balancing his schedule with gym sessions, trekking, and OTT binge-watching.

More from India

More from Scrip